Cargando…
Decisions by regulatory agencies: are they evidence-based?
Contradictory statements about the non-steroidal anti-inflammatory drugs from the European Medicines Agency and the United States Food and Drug Administration have raised questions about whether regulatory decisions are evidence-based. For the selective COX-2 inhibitors, there are clear contraindica...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852571/ https://www.ncbi.nlm.nih.gov/pubmed/17428328 http://dx.doi.org/10.1186/1745-6215-8-13 |